Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
Acutus Medical, Inc. specializes in advanced cardiac mapping and ablation technologies, primarily targeting atrial fibrillation (AF) treatment. The company differentiates itself through its proprietary AcQMap system, which offers real-time, high-resolution mapping of cardiac arrhythmias, positioning it favorably against traditional electrophysiology solutions.
Acutus generates revenue primarily through the sale of its AcQMap systems and related disposables, which have high margins due to their innovative technology. The company benefits from a recurring revenue model through service contracts and disposables, enhancing customer retention and providing stable cash flows.
Regulatory approvals for new products or indications, such as expanded uses for the AcQMap system
Partnerships or collaborations with major hospitals or healthcare systems
Market penetration rates in key regions, particularly in Europe and North America
Advancements in clinical outcomes data supporting the efficacy of AcQMap technology
Technological disruption from emerging cardiac mapping technologies
Regulatory changes impacting device approval processes
Intense competition from established players like Abbott and Medtronic in the electrophysiology market
Potential for new entrants with innovative technologies
High net margin loss indicates potential liquidity issues if revenue growth does not continue
Dependence on continued investment in R&D without immediate revenue generation
moderate - The demand for medical devices is somewhat insulated from economic cycles, but elective procedures like AF treatments can be affected by consumer spending and healthcare budgets.
Higher interest rates could increase financing costs for hospitals and healthcare providers, potentially impacting their capital expenditures on new technologies like AcQMap.
minimal - The company does not rely heavily on credit markets for operations, given its current low debt levels.
growth - Investors looking for high-growth potential in the medical device sector will find Acutus appealing due to its innovative technology and strong revenue growth.
high - The stock has shown significant volatility, particularly with a recent 95% decline in one year, indicating high sensitivity to market perceptions and operational performance.
